TickerFacts.

Compare

KORU Medical Systems, Inc. vs SS Innovations International, Inc. vs Interpace Biosciences, Inc. vs Utah Medical Products Inc

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearKORU Medical Systems, Inc.
KRMD		SS Innovations International, Inc.
SSII		Interpace Biosciences, Inc.
IDXG		Utah Medical Products Inc
UTMD
Year ended2025-12-312025-12-312025-12-312025-12-31
Revenue$41.13M$42.48M$38.73M$38.52M
Revenue growth (YoY)+22.2%+105.7%-17.5%-5.8%
Gross margin62.3%46.0%62.3%57.1%
Operating margin-7.2%-19.3%10.5%29.6%
Net margin-6.4%-28.5%63.5%29.3%
Net income-$2.64M-$12.13M$24.57M$11.29M
EPS (Diluted)-$0.06-$0.06$0.89$3.48
Operating cash flow$462.4K-$18.54M$5.83M$14.69M
Free cash flow-$470.1K-$22.20M$5.47M$14.32M
Cash & equivalents$8.87M$3.21M$2.50M$85.76M
Total assets$28.20M$74.23M$33.84M$122.54M
Total liabilities$11.15M$36.01M$11.47M$3.27M
Shareholders' equity$17.05M$38.22M$22.36M$119.27M
Return on year-end equity-15.5%-31.7%109.9%9.5%
Shares outstanding46.37M194.17M4.43M3.19M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearKORU Medical Systems, Inc.SS Innovations International, Inc.Interpace Biosciences, Inc.Utah Medical Products Inc
Latest$41.13M
Ended 2025-12-31		$42.48M
Ended 2025-12-31		$38.73M
Ended 2025-12-31		$38.52M
Ended 2025-12-31
1 year earlier$33.65M
Ended 2024-12-31		$20.65M
Ended 2024-12-31		$46.93M
Ended 2024-12-31		$40.90M
Ended 2024-12-31
2 years earlier$28.52M
Ended 2023-12-31		$5.88M
Ended 2023-12-31		$40.04M
Ended 2023-12-31		$50.22M
Ended 2023-12-31
3 years earlier$27.90M
Ended 2022-12-31		$1.44M
Ended 2022-12-31		$31.84M
Ended 2022-12-31		$52.28M
Ended 2022-12-31
4 years earlier$23.49M
Ended 2021-12-31		n/a$33.12M
Ended 2021-12-31		$49.05M
Ended 2021-12-31